M&A

We are pleased to announce the addition of Justin Nuta to our Corporate Law, Mergers & Acquisitions, and Tax departments. A legal professional awaiting admission to the Paris Bar, Justin holds a Master’s degree in Business Law and a Magistère in Business Law (D.J.C.E.) from Université Paris II Panthéon-Assas, as well as an LL.M. from… Continue reading Justin Nuta joins EQA

We are pleased to welcome Margot De Almeida Lopes as an associate in the M&A / Corporate Law & Tax departments. Margot holds a Master II in Internal and International Contract Law from the University of Paris-Saclay as well as a Master I in Business Law. We extend our best wishes for her success within… Continue reading Margot De Almeida Lopes joins EQA

On the occasion of its first round of financing completed in November 2023, Epron Quievy & Associés advised Proclus SAS, a leading independent French player in the reuse of professional electrical equipment. Proclus SAS is a fresh company set up in 2022 addressing the market with removed, requalified and reconditioned used technical equipment. Within its… Continue reading Épron Quievy & Associé advised Proclus SAS within its structuring and its first fundraising

After a first fundraising in 2021, Paltech SAS closed in October 2023 a new round of more than one million euros fully subscribed by private investors. Founded by doctors Réginald Allouche and Charles-Henri Malbert in 2021, Paltech SAS is an innovative company dedicated to the research for a curative treatment for type 2 diabetes.

Creapharm group has acquired a majority stake in the LinBox group, a French private biobank specializing in cryopreservation. The market for innovative therapeutics is burgeoning. The highly secure preservation and storage of these products, as well as its logistics, is now a real challenge for pharmaceutical laboratories, biotechnology companies and research centres. By choosing to… Continue reading Étienne Épron advised LinBox within its takeover by Creapharm group